New Webinar: Novel Interventions for Preempting Neurodegeneration

by admin | Jun 11, 2024 | news articles

by The Kitalys Institute – FRIDAY JUNE 14, 2024 Co-Moderators Lee Rubin, PhD, Professor of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute and Lawrence Steinman, MD, Zimmermann Professor of Neurology & Neurological Sciences, and Pediatrics...

Buck Institute and Sens.ai collaborate on brain aging study

by admin | Jun 11, 2024 | news articles

By Eleanor Garth – Longevity.Technology – Sens.ai, a brain coaching platform that leverages neurotech and AI to improve cognitive healthspan, and Eric Verdin, President and CEO of the Buck Institute for Research on Aging have announced a collaboration to...

6 Longevity Economy Principles – The World Economic Forum Weighs In

by admin | Jun 10, 2024 | news articles

By Avivah Wittenberg-Cox – Forbes – In an era where global life expectancy continues to rise, fertility falls and countries are shrinking demographically, the World Economic Forum’s new Longevity Economy Principles are not just timely—they’re...

AI Reasoning Flaws: The Limits of Popular Large Language Models

by admin | Jun 8, 2024 | news articles

By Neuroscience News – Popular AI platforms like ChatGPT give inconsistent answers to reasoning tests and don’t improve with added context. The research highlights the need to understand AI ‘thinking’ before using them for decision-making. Despite advances, AI...

How Sinclair, Johnson, and Hyman reversed their biological age – and how you can too

by admin | Jun 7, 2024 | news articles

By Jo Pinon – Longevity.Technology – Imagine waking up every morning with the vitality and energy of someone a decade younger. This isn’t a fantasy – it’s a reality for Dr David Sinclair, Bryan Johnson, and Dr Mark Hyman. These men claim to have reversed...

Turn Bio inks $300m epigenetic reprogramming deal with HanAll Biopharma

by admin | Jun 4, 2024 | news articles

by Danny Sullivan – Longevity.Technology – Longevity biotech Turn Biotechnologies today announced it has signed an exclusive global licensing agreement with Korean pharma giant HanAll Biopharma. The collaboration aims to develop multiple epigenetic...